arginine and alpha-synuclein

arginine has been researched along with alpha-synuclein in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (16.67)29.6817
2010's4 (66.67)24.3611
2020's1 (16.67)2.80

Authors

AuthorsStudies
Carver, JA; Ecroyd, H1
Brower, CS; Piatkov, KI; Varshavsky, A1
Dong, DW; Fina, M; Han, X; Kashina, A; Kurosaka, S; Lee, VM; Leu, NA; Sterling, S; Wang, J; Yates, JR1
Ghosh, D; Jha, NN; Kumar, A; Kumar, R; Maji, SK; Mehra, S; Navalkar, A; Padinhateeri, R; Panigrahi, R; Ranganathan, S1
Chattopadhyay, K; Ghosh, S; Kundu, A1
Kashina, A; Pan, B; Petersson, EJ; Rhoades, E; Shimogawa, M; Zhao, J1

Other Studies

6 other study(ies) available for arginine and alpha-synuclein

ArticleYear
The effect of small molecules in modulating the chaperone activity of alphaB-crystallin against ordered and disordered protein aggregation.
    The FEBS journal, 2008, Volume: 275, Issue:5

    Topics: alpha-Crystallin B Chain; alpha-Synuclein; Amyloid; Animals; Arginine; Caseins; Cattle; Cytoprotection; Guanidine; Hot Temperature; Humans; Insulin; Lactalbumin; Mutation; Parkinson Disease

2008
Neurodegeneration-associated protein fragments as short-lived substrates of the N-end rule pathway.
    Molecular cell, 2013, Apr-25, Volume: 50, Issue:2

    Topics: alpha-Synuclein; Amino Acid Sequence; Amyloid beta-Protein Precursor; Animals; Arginine; Brain; Calpain; Cell Extracts; DNA-Binding Proteins; Frontotemporal Lobar Degeneration; Half-Life; HEK293 Cells; Humans; Matrix Metalloproteinase 3; Mice; Mice, Transgenic; Molecular Sequence Data; Neurodegenerative Diseases; NIH 3T3 Cells; Peptide Fragments; Protein Stability; Proteolysis; Reticulocytes; Saccharomyces cerevisiae; tau Proteins

2013
Protein arginylation targets alpha synuclein, facilitates normal brain health, and prevents neurodegeneration.
    Scientific reports, 2017, 09-12, Volume: 7, Issue:1

    Topics: alpha-Synuclein; Amino Acid Sequence; Aminoacyltransferases; Animals; Arginine; Brain; Cells, Cultured; Disease Models, Animal; Humans; Mass Spectrometry; Mice; Mice, Knockout; Models, Biological; Neurodegenerative Diseases; Neurons; Peptides; Protein Aggregates; Protein Aggregation, Pathological; Protein Processing, Post-Translational; Proteolysis; Recombinant Proteins; Substrate Specificity

2017
Complexation of NAC-Derived Peptide Ligands with the C-Terminus of α-Synuclein Accelerates Its Aggregation.
    Biochemistry, 2018, 02-06, Volume: 57, Issue:5

    Topics: alpha-Synuclein; Amino Acid Substitution; Amyloid; Arginine; Cell Line, Tumor; Drug Design; Humans; Hydrophobic and Hydrophilic Interactions; Ligands; Molecular Dynamics Simulation; Neuroblastoma; Nuclear Magnetic Resonance, Biomolecular; Peptide Fragments; Protein Aggregates; Protein Aggregation, Pathological; Protein Domains; Surface Plasmon Resonance

2018
Small Molecules Attenuate the Interplay between Conformational Fluctuations, Early Oligomerization and Amyloidosis of Alpha Synuclein.
    Scientific reports, 2018, 04-03, Volume: 8, Issue:1

    Topics: alpha-Synuclein; Amyloid; Arginine; Glutamic Acid; HeLa Cells; Humans; Kinetics; Protein Multimerization; Protein Structure, Secondary; Small Molecule Libraries

2018
Cysteine-Based Mimic of Arginylation Reproduces Neuroprotective Effects of the Authentic Post-Translational Modification on α-Synuclein.
    Journal of the American Chemical Society, 2022, 05-04, Volume: 144, Issue:17

    Topics: alpha-Synuclein; Arginine; Cysteine; Neuroprotective Agents; Protein Processing, Post-Translational

2022